Information about and link to Attana’s presentation at Redeye’s R&D Tools Seminar
Yesterday, Tuesday November 10th, Redeye arranged an online seminar where Attana presented the latest information about the company.
Yesterday at Redeye’s R&D Tools seminar, Teodor Aastrup, Attana CEO and Niklas Carlsson, Attana’s newly appointed COO and VP, presented the latest information and answered questions about the company and outlook.
The full presentation and Q&A session is available here on Redeye’s website (in English).
For more information, please contact:
Teodor Aastrup, CEO Attana AB
tel: + 46 8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org